Marine algae exhibit broad spectrum anti-bacterial and anti-inflammatory activities. Acrosorium polyneurum (A. polyneurum) is a marine red alga and belongs to the family Delesseriaceae. The present research evaluates the antiinflammatory effects of A. polyneurum extract (APE) on pro-inflammatory cytokine production. APE demonstrated substantial inhibitory effects on production of pro-inflammatory cytokine in bone marrow-derived macrophages (BMDMs). APE pre-treatment in the lipopolysaccharide (LPS)-stimulated BMDMs exhibited a robust inhibitory effect on production of interleukin (IL)-12, IL-6 and tumor necrosis factor (TNF)-α. It revealed a robust inhibitory effect on phosphorylation of ERK1/2, JNK1/2 and p38. APE also showed remarkable inhibitory effect on phosphorylation and degradation of IκBα. Furthermore, APE pre-treatment demonstrated substantial inhibition of LPS-induced production of nitric oxide and inducible nitric oxide synthase. Collectively, these data suggest that APE has a noteworthy anti-inflammatory property and deserve further studies concerning its potential use as a medicinal agent for inflammation-related disorders.
INTRODUCTION
TLRs are the main regulator of innate host immune response against harmful stimuli (1) . For example, TLR4 expressed in macrophages recognizes lipopolysaccharide (LPS) and results in activation of different signaling cascades, such as nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) pathway, leading to pro-inflammatory cytokine production (7).
Phytochemicals have been major bioresources and explored well for medicinal use (8) . Now scientists are exploring natural products from marine bioresources. A large number of biomaterials for good bioactivities have been documented, but much still remains to be explored for high nutritional value and pharmaceutical potential (9) . Red algae 288 are known as oldest multicellular plants and most diverse eukaryotes (10) . Red algae are the largest species among algae, providing a good resource for medicinal food and helpful in different ways in food industry. For example, carrageenans are sulphated polysaccharides, extracted from red algae and widely used in the food industry for gelling or stabilizing activities. Several red algae are good source of food and some are used in preparing agars (11) . Extracts from marine algae have been reported to exhibit broad spectrum anti-bacterial, anti-inflammatory and antioxidant activities (12, 13) . Acrosorium polyneurum (A. polyneurum), a marine red alga, belongs to the family Delesseriaceae and is distributed on the seashores of Korea. During ongoing research to evaluate the biological effects of various marine alga extracts, in the present study, A. polyneurum extract (APE) was studied for the anti-inflammatory properties for the first time.
The effect of APE has not been studied regarding its impact on primary murine macrophages. Thus, in the present study we report for the anti-inflammatory effects of APE on LPSstimulated bone marrow-derived macrophages (BMDMs) and RAW 264.7 cells.
MATERIALS AND METHODS

Preparation of A. polyneurum extract
Thalli of A. polyneurum were collected on Jeju Island, Korea. The material for extraction was cleaned, dried at room temperature and fine powder was made by grinding.
The dried alga was extracted as described previously (13) .
The evaporated ethanol extract was suspended in water. 
Cell viability assay
To assess cell viability, the standard procedure of 3-(4,5-dimethyl-2,5 thiazolyl)-2,5 diphenyl tetrazolium bromide (MTT) assay was used as described previously (17) .
Western blot analysis
Western blot analysis was performed using standard techniques as previously described (18, 19) . Briefly, BMDMs and RAW264.7 cells were dispensed to 60-mm culture dishes bands were detected as previously described (19) .
Statistical analysis
All experiments were executed at least 3 times. The data are shown as the mean ± the standard deviation (SD) of 3 independent experiments. One-way ANOVA (SPSS program; IBM, Armonk, NY, USA) was used for comparison between treated and control groups. p < 0.05 was considered to be statistically significant.
RESULTS AND DISCUSSION
Effects of APE on pro-inflammatory cytokine production in LPS-stimulated BMDMs
Cytokines are required to regulate host responses to inflammation and macrophages are the key producers of various cytokines (1). BMDMs express TLR4 that recognizes LPS and leads to the production of cytokines (20) . Therefore, we determined the anti-inflammatory activity of APE by testing its inhibitory effects on IL-12, IL-6 and TNF-α production in LPS-stimulated BMDMs. The maximal concentration of APE for treating cells was assessed by MTT assay, and as a result, APE had no effect on the cell viability at indicated concentrations (data not shown). LPS induced a substantial increase of pro-inflammatory cytokine production in BMDMs. APE pre-treatment profoundly inhibited proinflammatory cytokine production in the LPS-stimulated BMDMs (Fig. 1) . These results show that APE had an inhibitory effect on production of cytokines in LPS-stimulated ), BMDMs were treated with APE at various doses as shown for 1 h and cytokines levels were assessed by ELISA. ND, not detectable; APE, A. polyneurum extract. *p < 0.05, **p < 0.01 vs. APE-untreated cells in the presence of LPS.
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inflammatory diseases (23, 24) . Thus in future, controlling the over production of IL-6 and TNF-α by APE might be helpful in ameliorating inflammation-associated diseases such as autoimmune and autoinflammatory diseases. and NF-κB, and leads to the production of cytokines (1, 25) .
Henceforth, we studied the effects on MAPK phosphorylation and NF-κB activation in LPS-stimulated BMDMs, with and without APE treatment by Western blot analysis ( Fig. 2 and 3) . Stimulation of BMDMs with LPS resulted in phosphorylation of ERK1/2, JNK1/2 and p38 MAPKs.
APE pre-treatment in the presence of LPS displayed robust inhibition of MAPKs phosphorylation ( Fig. 2A, B) . Together, these data suggest that APE can inhibit LPS-stimulated ERK1/2, JNK1/2 and p38 phosphorylation in BMDMs. (Fig. 3) . In the presence of LPS, APE pre-treatment showed substantial inhibition of IκBα phosphorylation (Fig. 3A and B) . Activation of NF-κB was also evaluated indirectly through the degradation of IκBα. LPS-stimulation resulted in degradation of IκBα within 15 min of stimulation ( Fig. 3A and B) . APE pretreatment inhibited IκBα degradation, and as a consequence is likely to inhibit the activation of NF-κB in LPS-stimulated BMDMs ( Fig. 3A and B) . Collectively, these data propose that APE inhibited the NF-κB activation. Taken together, these findings advocate that inhibition of LPS-stimulated pro-inflammatory cytokines production by APE may associate with blockage of the MAPK and NF-κB-dependent pathway.
Effect of APE on the production of NO and iNOS in LPS-stimulated RAW264.7 cells RAW 264.7 cells express TLR4 that recognizes LPS and leads to the production of NO (26, 27) . Therefore, the effect of APE on production of NO in LPS-induced RAW 264.7 cells was tested with Griess assay. To measure the cell viability at the same time, colorimetric MTT assay was used, and as a result, APE had no adverse effect on the viability of cells at the indicated doses (data not shown). LPS induced a significant increase of NO production in RAW264.7 cells. APE pre-treatment strongly inhibited NO production in the LPS-stimulated RAW264.7 cells (Fig. 4A) . We performed Western blot analysis to explore the effect of APE on the production of iNOS in LPS-stimulated RAW264.7 cells.
LPS-stimulation exhibited a strong increase in the iNOS production in RAW264.7 cells (Fig. 4B and C) . However, APE pre-treatment significantly inhibited iNOS expression in LPS-stimulated RAW264.7 cells (Fig. 4B and 4C ). Overexpression of iNOS has been linked with different diseases, including arthritis, septic shock and chronic inflammatory diseases (27) . The present study proposes that APE has an inhibitory effect on the iNOS production and might be helpful in treating inflammatory diseases.
In conclusion, we established that APE had an inhibitory effect on the pro-inflammatory cytokines production by diminishing MAPKs and NF-κB signaling pathways. APE also showed inhibition of NO production by down regulating iNOS expression and, thus, deserves further study regarding its potential use as a medicinal agent. In addition, these results suggest that APE might be helpful in the treatment of inflammation-associated diseases. Hence, further studies are mandatory regarding comprehensive analysis and detailed mode of actions of the pure active components of APE.
